Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-02-26 @ 4:16 PM
Study NCT ID:
NCT02722733
Status:
UNKNOWN
Last Update Posted:
2016-03-30
First Post:
2016-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2017-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-04
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-11
First Submit QC Date:
None
Study First Post Date:
2016-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-24
Last Update Post Date:
2016-03-30
Last Update Post Date Type:
ESTIMATED